Company Filing History:
3 out of 1,976 
1 out of 27 
1 out of 712 
Years Active: 1995-1998
Title: The Innovations of David Edwin Lyons
Introduction
David Edwin Lyons is a notable inventor based in Thousand Oaks, CA. He has made significant contributions to the field of biochemistry, particularly through his work on human serum proteins. With a total of 3 patents, Lyons has demonstrated a commitment to advancing scientific knowledge and innovation.
Latest Patents
One of his latest patents is titled "Afamin: a human serum albumin-like protein." This invention relates to a novel human serum protein referred to as AFM, which shares activities with human serum albumin, human a-fetoprotein, or human vitamin D binding protein. The protein has an apparent molecular weight of 87 kd as determined by SDS-PAGE. Additionally, he has patented "Afamin: a human serum albumin-like gene," which encompasses the nucleic acid associated with the AFM protein, including its variants and related genes, vectors, and methods.
Career Highlights
Throughout his career, David Edwin Lyons has worked with prominent organizations such as Amgen Inc. and The Rockefeller University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Henri Stephen Lichenstein and Samuel D. Wright. Their collective efforts have furthered the understanding of serum proteins and their applications in medicine.
Conclusion
David Edwin Lyons is a distinguished inventor whose work on human serum proteins has the potential to impact various medical fields. His patents reflect a deep understanding of biochemistry and a dedication to innovation.